Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05280431Not ApplicableCompleted

Evaluation of Exoskeleton for Upper Limb Rehabilitation in Neurological Patients

Role: lead

NCT05538455Not ApplicableCompleted

Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases

Role: lead

NCT05871359Not ApplicableUnknown

Transcranial Direct Current Stimulation and Dual Tasks

Role: lead

NCT04173975Not ApplicableWithdrawn

Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting (BELK@CCP)

Role: lead

NCT03418883Not ApplicableCompleted

Mirror Therapy Efficacy in Upper Limb Rehabilitation Early After Stroke

Role: lead

All 5 trials loaded